Abstract
The COVID-19 pandemic hit the world in 2020. At the end of April 2021, according to the World Health Organization (WHO), 140,332,386 people worldwide suffered COVID-19, of which 3,004,088 were recorded.
It is therefore the subject of intensive research not only in the field of medicine, but due to the significant impact of life on anti-epidemic measures on this topic and goals in terms of education, economics and the general public. The causative agent of the disease is the coronavirus SARS-CoV-2, which belongs to the family Coronaviridae and belongs to the other six coronaviruses discovered so far, which also cause human respiratory diseases.
The association between viral and autoimmune diseases is well known, although the exact mechanisms remain unclear. Works documenting the onset of autoimmune disease as a result of SARS-CoV-2 are beginning to appear in the literature.
In addition to neurological and rheumatological reports, there are also reports of newly diagnosed type 1 diabetes mellitus. In the University Hospital in Hradec Králové in the years 2020 and 2021, we recorded a total of 4 young patients who were newly diagnosed with diabetes.
The role of COVID-19 in the development of diabetes is possible due to the clinical sequence.